The FDA is offering this grant through its Safe Use Initiative to reduce preventable harm from suboptimal use of regulated prescription and over-the-counter medications. This grant is for research that characterizes preventable harm linked to specific FDA-regulated drugs, identifies its root causes, and develops and implements interventions to reduce it. The approach involves cross-sector collaborations with healthcare partners committed to medication safety. This opportunity provides resources to advance solutions for safer medication practices, ultimately enhancing public health by promoting the safe use of medications.
Opportunity ID: 100053
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-FD-11-024 |
| Funding Opportunity Title: | Novel Interventions and Collaborations to Improving the Safe Use of Medications (U01) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | CategoryExplanation |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Agriculture Business and Commerce Community Development Education Employment, Labor and Training Environment Food and Nutrition Health Information and Statistics Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 5 |
| Assistance Listings: | 93.103 — Food and Drug Administration_Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jun 17, 2011 |
| Last Updated Date: | Jun 22, 2011 |
| Original Closing Date for Applications: | Jul 18, 2011 |
| Current Closing Date for Applications: | Jul 18, 2011 |
| Archive Date: | Jul 19, 2011 |
| Estimated Total Program Funding: | $250,000 |
| Award Ceiling: | $50,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | County governments Public housing authorities/Indian housing authorities Small businesses State governments Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Private institutions of higher education |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Food and Drug Administration |
| Description: | As part of FDA’s Safe Use Initiative: Collaborating to Reduce Preventable Harm, FDA will identify drug/drug classes or therapeutic areas associated with preventable harm. The mission of the Safe use Initiative is to seek solutions to preventable harm associated with suboptimal use of regulated prescription and over the counter medications. The approach is to involve cross sector collaborations with other parts of healthcare committed to medication safety. This Funding Opportunity Announcement (FOA), issued by FDA, will provide resources for research to characterize preventable harm associated with specific FDA regulated drugs, identify sources (root causes) of the preventable harm and for the development and implementation of interventions to reduce the preventable harm. |
| Link to Additional Information: | NIH Guide for Grants and Contracts |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Stephanie Bogan
Grants Management Specialist Email:stephanie.bogan@fda.hhs.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Jun 22, 2011 | ||
| Jun 22, 2011 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-FD-11-024 |
| Funding Opportunity Title: | Novel Interventions and Collaborations to Improving the Safe Use of Medications (U01) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | CategoryExplanation |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Agriculture Business and Commerce Community Development Education Employment, Labor and Training Environment Food and Nutrition Health Information and Statistics Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 5 |
| Assistance Listings: | 93.103 — Food and Drug Administration_Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jun 17, 2011 |
| Last Updated Date: | Jun 22, 2011 |
| Original Closing Date for Applications: | Jul 18, 2011 |
| Current Closing Date for Applications: | Jul 18, 2011 |
| Archive Date: | Jul 19, 2011 |
| Estimated Total Program Funding: | $250,000 |
| Award Ceiling: | $50,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | County governments Public housing authorities/Indian housing authorities Small businesses State governments Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Private institutions of higher education |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Food and Drug Administration |
| Description: | As part of FDA’s Safe Use Initiative: Collaborating to Reduce Preventable Harm, FDA will identify drug/drug classes or therapeutic areas associated with preventable harm. The mission of the Safe use Initiative is to seek solutions to preventable harm associated with suboptimal use of regulated prescription and over the counter medications. The approach is to involve cross sector collaborations with other parts of healthcare committed to medication safety. This Funding Opportunity Announcement (FOA), issued by FDA, will provide resources for research to characterize preventable harm associated with specific FDA regulated drugs, identify sources (root causes) of the preventable harm and for the development and implementation of interventions to reduce the preventable harm. |
| Link to Additional Information: | NIH Guide for Grants and Contracts |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Stephanie Bogan
Grants Management Specialist Email:stephanie.bogan@fda.hhs.gov |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-FD-11-024 |
| Funding Opportunity Title: | Novel Interventions and Collaborations to Improving the Safe Use of Medications (U01) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Agriculture Business and Commerce Community Development Education Employment, Labor and Training Environment Food and Nutrition Health Information and Statistics Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 5 |
| Assistance Listings: | 93.103 — Food and Drug Administration_Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jun 22, 2011 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jul 18, 2011 |
| Archive Date: | Jul 19, 2011 |
| Estimated Total Program Funding: | $250,000 |
| Award Ceiling: | $50,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | City or township governments Public and State controlled institutions of higher education State governments Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Public housing authorities/Indian housing authorities Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Individuals Small businesses County governments Native American tribal governments (Federally recognized) Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Food and Drug Administration |
| Description: | As part of FDA’s Safe Use Initiative: Collaborating to Reduce Preventable Harm, FDA will identify drug/drug classes or therapeutic areas associated with preventable harm. The mission of the Safe use Initiative is to seek solutions to preventable harm associated with suboptimal use of regulated prescription and over the counter medications. The approach is to involve cross sector collaborations with other parts of healthcare committed to medication safety.
This Funding Opportunity Announcement (FOA), issued by FDA, will provide resources for research to characterize preventable harm associated with specific FDA regulated drugs, identify sources (root causes) of the preventable harm and for the development and implementation of interventions to reduce the preventable harm. |
| Link to Additional Information: | NIH Guide for Grants and Contracts |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Stephanie Bogan
Grants Management Specialist Email:stephanie.bogan@fda.hhs.gov |
Related Documents
Folder 100053 Full Announcement-1 -> rfa-fd-11-024.pdf
Folder 100053 Full Announcement-2 -> sf424_rr_guide_general_adobe_verb.pdf
Packages
| Agency Contact Information: | Stephanie Bogan Grants Management Specialist Email: stephanie.bogan@fda.hhs.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.103 | ADOBEFORMSB1 | AdobeFormsB1 | PKG00059830 | Jul 20, 2011 | Jul 21, 2011 | View |
Package 1
Mandatory forms
100053 RR_SF424_1_2-1.2.pdf
100053 RR_OtherProjectInfo_1_3-1.3.pdf
100053 RR_KeyPersonExpanded_1_2-1.2.pdf
100053 PerformanceSite_1_4-1.4.pdf
100053 PHS398_ResearchPlan_1_3-1.3.pdf
100053 PHS398_CoverPageSupplement_1_4-1.4.pdf
100053 PHS398_Checklist_1_3-1.3.pdf
Optional forms
100053 RR_Budget-1.1.pdf
100053 RR_SubawardBudget-1.2.pdf
100053 PHS_CoverLetter_1_2-1.2.pdf
100053 PHS398_ModularBudget-1.1.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
